Primary ectopic axillary breast cancer: a case series.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
31 Jul 2021
Historique:
received: 11 02 2021
accepted: 29 06 2021
entrez: 31 7 2021
pubmed: 1 8 2021
medline: 4 8 2021
Statut: epublish

Résumé

Ectopic breast tissue is present in 2-6% of women. Ectopic breast cancer represents an uncommon disease accounting for about 0.3% of all breast neoplasms, limiting the available evidence. Thus, we aim to report long-term outcomes in five cases treated at our institution. Our Tunisian patients' median age was 48 years (33-60 years), and the median follow-up was 8 years (4-10 years). The ectopic breast tissue was located four times in the right axilla. The median tumor size was 25 mm (15-55 mm). Four of the patients underwent a wide local excision and axillary lymph node dissection. Three of those women had positive lymph nodes; thus, they received adjuvant chemotherapy, radiation therapy, and hormone therapy. The patient with a negative lymph node (case 5) had adjuvant radiation therapy and hormonal therapy. One of the patients (case 1) had a positive supraclavicular lymph node and received radiation therapy, chemotherapy, and hormonal therapy. The latter developed a locoregional relapse after 4 years and was treated with mastectomy and chemotherapy. One patient (case 4) had a distant metastasis after 2 years of follow-up and received chemotherapy. The three other patients were free of relapse during their follow-up period. Primary axillary breast carcinoma is a rare entity. Despite the paucity of literature, our findings and authors' recommendations suggest that local excision can be performed safely with promising outcomes in this subset of patients.

Identifiants

pubmed: 34330331
doi: 10.1186/s13256-021-02998-w
pii: 10.1186/s13256-021-02998-w
pmc: PMC8325209
doi:

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

412

Informations de copyright

© 2021. The Author(s).

Références

Dermatol Surg. 2005 Feb;31(2):237-9
pubmed: 15762222
Surg Oncol. 1994 Oct;3(5):295-304
pubmed: 7889223
Pan Afr Med J. 2012;13:50
pubmed: 23330041
Surg Oncol. 2011 Mar;20(1):35-42
pubmed: 19853438
Am Surg. 1961 May;27:388-90
pubmed: 13694314
Ann Dermatol Venereol. 2002 Dec;129(12):1389-91
pubmed: 12536178
Acta Cytol. 1995 Sep-Oct;39(5):941-4
pubmed: 7571974
J Korean Med Sci. 2001 Aug;16(4):519-21
pubmed: 11511802
Breast Cancer. 1997 Mar 25;4(1):43-48
pubmed: 11091576
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:423-8
pubmed: 16515638
Aesthetic Plast Surg. 2013 Aug;37(4):746-9
pubmed: 23620009
Arch Pathol Lab Med. 2001 Oct;125(10):1372-4
pubmed: 11570920
Ann Chir Plast Esthet. 1991;36(5):457-9
pubmed: 1726395
J Natl Med Assoc. 1982 Jan;74(1):37-8
pubmed: 7120440
Radiology. 1987 Jun;163(3):709-11
pubmed: 3575719
BMJ Case Rep. 2019 Jan 24;12(1):
pubmed: 30679228
Breast J. 2002 Sep-Oct;8(5):286-9
pubmed: 12199756
Trop Geogr Med. 1984 Mar;36(1):45-9
pubmed: 6328710
J Am Acad Dermatol. 2003 Dec;49(6):1154-6
pubmed: 14639406
Anticancer Res. 1998 Sep-Oct;18(5B):3737-40
pubmed: 9854486
J Surg Oncol. 1995 Jul;59(3):190-5
pubmed: 7609527
J Plast Reconstr Aesthet Surg. 2011 Jan;64(1):e1-11
pubmed: 20934398
Am Surg. 2004 Apr;70(4):312-5
pubmed: 15098783
Diagn Gynecol Obstet. 1982 Summer;4(2):141-5
pubmed: 6284467
Minerva Ginecol. 1984 Oct;36(10):623
pubmed: 6527816
Oncol Rep. 1998 Mar-Apr;5(2):413-7
pubmed: 9468570
Cancer. 1976 Dec;38(6):2570-4
pubmed: 187318
Surg Clin North Am. 1950 Dec;30(6):1717-41
pubmed: 14787886

Auteurs

S Sghaier (S)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia. Sarah.sghaier91@gmail.com.

M GHalleb (M)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia.

I Marghli (I)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia.

A Bouida (A)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia.

J Ben Hassouna (J)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia.

R Chargui (R)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia.

K Rahal (K)

Surgical oncology department, Salah Azaiez Institute of cancer, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH